Harrow Health

$5.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.67%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell Harrow Health and other stocks, options, and ETFs commission-free!

About HROW

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN. The listed name for HROW is Harrow Health, Inc. Common Stock.

CEO
Mark L. Baum
Employees
133
Headquarters
Nashville, Tennessee
Founded
2006
Market Cap
153.45M
Price-Earnings Ratio
Dividend Yield
Average Volume
193.76K
High Today
$6.20
Low Today
$5.86
Open Price
$6.09
Volume
120.95K
52 Week High
$7.92
52 Week Low
$3.33

Collections

HROW Earnings

-$0.50
-$0.19
$0.12
$0.43
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 8, After Hours

You May Also Like